What is spinal muscular atrophy (SMA)?

SMA is a rare, often fatal genetic disease causing paralysis, muscle weakness, and progressive loss of movement.

How much did the Zolgensma drug cost for Edward?

The gene therapy, Zolgensma, cost approximately $2.4 million per dose, making it the world's most expensive drug.

Did Edward receive Zolgensma in the UK?

Yes, Edward was one of the first children in England to receive Zolgensma through the National Health Service (NHS) in 2021.

Home / Health / Miracle Drug Helps Boy Walk After Rare Genetic Disorder

Miracle Drug Helps Boy Walk After Rare Genetic Disorder

1 Jan

•

Summary

A 5-year-old boy with SMA can now walk independently after treatment.
He received Zolgensma, the world's most expensive drug at $2.4 million.
The gene therapy was administered in 2021 through the UK's NHS.

Miracle Drug Helps Boy Walk After Rare Genetic Disorder

Edward, a 5-year-old boy from Essex, UK, has achieved remarkable milestones, including walking independently, after receiving a revolutionary gene therapy. Diagnosed with spinal muscular atrophy (SMA) at two months old, Edward was treated in 2021 with Zolgensma, a drug costing approximately $2.4 million per dose. This treatment, administered through the UK's National Health Service, has significantly improved his quality of life.

His mother shared that Edward has made incredible progress, overcoming challenges associated with SMA. Beyond walking, he enjoys swimming and participating in activities like jet-skiing, demonstrating a quality of life previously considered unattainable for children with his condition. Despite needing a wheelchair and undergoing a double hip replacement, his spirit remains high.

Professor James Palmer of NHS England highlighted Edward as one of over 150 children benefiting from this one-shot treatment. This success story fuels optimism for future advancements in treating genetic disorders, with ongoing private care supporting Edward's continued development and well-being.